The Third Survey of Prescription Pattern of Psychotropic Drugs in China

NCT01668810 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 7000

Last updated 2012-08-20

No results posted yet for this study

Summary

The investigators aimed to examine the psychotropic prescription pattern in China.

Conditions

  • Prescription

Sponsors & Collaborators

  • Xian-Janssen Pharmaceutical Ltd.

    collaborator INDUSTRY
  • Peking University

    lead OTHER

Principal Investigators

  • Xin Yu, MD. · Peking University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2012-09-30
Completion
2013-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01668810 on ClinicalTrials.gov